Afshin Namdar

2.2k total citations
31 papers, 1.5k citations indexed

About

Afshin Namdar is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Afshin Namdar has authored 31 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 10 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Afshin Namdar's work include Immune Cell Function and Interaction (10 papers), Immunotherapy and Immune Responses (8 papers) and Adenosine and Purinergic Signaling (7 papers). Afshin Namdar is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Immunotherapy and Immune Responses (8 papers) and Adenosine and Purinergic Signaling (7 papers). Afshin Namdar collaborates with scholars based in Canada, Iran and Sweden. Afshin Namdar's co-authors include Farhad Jadidi‐Niaragh, Shokrollah Elahi, Ghasem Ghalamfarsa, Mohammad Hojjat‐Farsangi, Gholamreza Azizi, Parviz Kokhaei, Majid Eslami, Vahid Arabkari, Bahman Yousefi and Maral Hemati and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Scientific Reports.

In The Last Decade

Afshin Namdar

30 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Afshin Namdar Canada 23 665 586 410 282 152 31 1.5k
Ryusho Kariya Japan 24 594 0.9× 347 0.6× 453 1.1× 221 0.8× 72 0.5× 72 1.5k
Yi Rang Na South Korea 17 591 0.9× 692 1.2× 143 0.3× 143 0.5× 64 0.4× 31 1.4k
Peter Geserick Germany 14 1.5k 2.3× 721 1.2× 306 0.7× 350 1.2× 84 0.6× 21 2.1k
Sandrine Jouan-Lanhouet France 8 1.7k 2.5× 700 1.2× 340 0.8× 426 1.5× 50 0.3× 8 2.3k
Lukas F. Mager Canada 9 773 1.2× 513 0.9× 547 1.3× 85 0.3× 61 0.4× 15 1.5k
Sharon L. McKenna Ireland 26 1.4k 2.1× 211 0.4× 399 1.0× 353 1.3× 77 0.5× 64 2.3k
Kristina Iribarren France 15 387 0.6× 667 1.1× 382 0.9× 90 0.3× 98 0.6× 18 1.1k
Noriho Iida Japan 21 572 0.9× 526 0.9× 607 1.5× 157 0.6× 136 0.9× 50 1.6k
Hongwei Zhang China 20 492 0.7× 208 0.4× 220 0.5× 225 0.8× 129 0.8× 96 1.5k

Countries citing papers authored by Afshin Namdar

Since Specialization
Citations

This map shows the geographic impact of Afshin Namdar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afshin Namdar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afshin Namdar more than expected).

Fields of papers citing papers by Afshin Namdar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Afshin Namdar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afshin Namdar. The network helps show where Afshin Namdar may publish in the future.

Co-authorship network of co-authors of Afshin Namdar

This figure shows the co-authorship network connecting the top 25 collaborators of Afshin Namdar. A scholar is included among the top collaborators of Afshin Namdar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Afshin Namdar. Afshin Namdar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahmoudian, Mohammad, Afshin Namdar, Parvin Zakeri‐Milani, et al.. (2022). Interaction of M2 macrophages with hepatocellular carcinoma co-culture system in the presence of doxorubicin-loaded nanoparticles. Journal of Drug Delivery Science and Technology. 73. 103487–103487. 5 indexed citations
2.
Namdar, Afshin, et al.. (2021). Anti-tumor immunity in mismatch repair-deficient colorectal cancers requires type I IFN–driven CCL5 and CXCL10. The Journal of Experimental Medicine. 218(9). 86 indexed citations
3.
Izadi, Sepideh, Afshin Nikkhoo, Mohammad Hojjat‐Farsangi, et al.. (2020). CDK1 in Breast Cancer: Implications for Theranostic Potential. Anti-Cancer Agents in Medicinal Chemistry. 20(7). 758–767. 67 indexed citations
4.
Kiaie, Seyed Hossein, Mohsen Nabi‐Afjadi, Armin Ahmadi, et al.. (2020). Concomitant blockade of A2AR and CTLA‐4 by siRNA‐loaded polyethylene glycol‐chitosan‐alginate nanoparticles synergistically enhances antitumor T‐cell responses. Journal of Cellular Physiology. 235(12). 10068–10080. 33 indexed citations
5.
Moslemi, Masoumeh, et al.. (2020). Identification of key genes in breast cancer cell line under hypoxia condition: A bioinformatics analysis. 3(3). 62–69. 2 indexed citations
6.
Hashemi, Vida, Mitra Ghasemi Chaleshtari, Brinton Seashore‐Ludlow, et al.. (2020). Nanomedicine for improvement of dendritic cell-based cancer immunotherapy. International Immunopharmacology. 83. 106446–106446. 32 indexed citations
7.
Masjedi, Ali, Shahin Hallaj, Mohsen Nabi‐Afjadi, et al.. (2020). Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine. Journal of Controlled Release. 326. 63–74. 59 indexed citations
8.
Hajizadeh, Farnaz, Ali Masjedi, Sepideh Izadi, et al.. (2020). Combined inhibition of CD73 and ZEB1 by Arg-Gly-Asp (RGD)-targeted nanoparticles inhibits tumor growth. Colloids and Surfaces B Biointerfaces. 197. 111421–111421. 21 indexed citations
9.
Karpisheh, Vahid, Navneet Joshi, Angelina Olegovna Zekiy, et al.. (2020). EP4 receptor as a novel promising therapeutic target in colon cancer. Pathology - Research and Practice. 216(12). 153247–153247. 28 indexed citations
10.
Hassannia, Hadi, Mitra Ghasemi Chaleshtari, Fatemeh Atyabi, et al.. (2019). Blockage of immune checkpoint molecules increases T‐cell priming potential of dendritic cell vaccine. Immunology. 159(1). 75–87. 62 indexed citations
11.
Hashemi, Vida, Leili Aghebati‐Maleki, Ali Masjedi, et al.. (2019). Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target. International Immunopharmacology. 78. 106087–106087. 42 indexed citations
12.
Shabaninejad, Zahra, Asma Vafadar, Ahmad Movahedpour, et al.. (2019). Circular RNAs in cancer: new insights into functions and implications in ovarian cancer. Journal of Ovarian Research. 12(1). 84–84. 114 indexed citations
13.
Mohammadi, Mohammad Mahdi, et al.. (2019). Natural Killer Cells Exhibit an Activated Phenotype in Peripheral Blood Mononuclear Cells of Renal Allograft Rejection Recipients: A Preliminary Study. Experimental and Clinical Transplantation. 17(4). 490–497. 3 indexed citations
14.
Namdar, Afshin, Garett Dunsmore, Shima Shahbaz, et al.. (2019). CD71 + Erythroid Cells Exacerbate HIV-1 Susceptibility, Mediate trans -Infection, and Harbor Infective Viral Particles. mBio. 10(6). 32 indexed citations
15.
Shahbaz, Shima, Najmeh Bozorgmehr, Petya Koleva, et al.. (2018). CD71+VISTA+ erythroid cells promote the development and function of regulatory T cells through TGF-β. PLoS Biology. 16(12). e2006649–e2006649. 65 indexed citations
16.
Namdar, Afshin, Petya Koleva, Shima Shahbaz, et al.. (2017). CD71+ erythroid suppressor cells impair adaptive immunity against Bordetella pertussis. Scientific Reports. 7(1). 7728–7728. 50 indexed citations
17.
Arab, Samaneh, Nasim Kheshtchin, Maryam Ajami, et al.. (2017). Increased efficacy of a dendritic cell–based therapeutic cancer vaccine with adenosine receptor antagonist and CD73 inhibitor. Tumor Biology. 39(3). 3726131102–3726131102. 53 indexed citations
18.
Kheshtchin, Nasim, Samaneh Arab, Maryam Ajami, et al.. (2016). Inhibition of HIF-1α enhances anti-tumor effects of dendritic cell-based vaccination in a mouse model of breast cancer. Cancer Immunology Immunotherapy. 65(10). 1159–1167. 76 indexed citations
19.
Samadi, Morteza, Rouhollah Vahabpour, Arash Memarnejadian, et al.. (2010). Immune responses regulation following antitumor dendritic cell-based prophylactic, concurrent, and therapeutic vaccination. Medical Oncology. 28(S1). 660–666. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryusho Kariya Breakdown of academic impact, for papers by Yi Rang Na Breakdown of academic impact, for papers by Peter Geserick Breakdown of academic impact, for papers by Sandrine Jouan-Lanhouet Breakdown of academic impact, for papers by Lukas F. Mager Breakdown of academic impact, for papers by Sharon L. McKenna Breakdown of academic impact, for papers by Kristina Iribarren Breakdown of academic impact, for papers by Noriho Iida Breakdown of academic impact, for papers by Hongwei Zhang
Rankless by CCL
2026